One of the most important questions for women considering fibroid treatment is: what are the chances of fibroids coming back? The honest answer depends heavily on which treatment you had, your age, and what you do after treatment. Here is the data.
Recurrence Rates By Treatment Type
Myomectomy: Fibroids recur in approximately 15–30% of women within 3 years of myomectomy, rising to 50–60% within 5–10 years. The risk is higher when multiple fibroids were present at the time of surgery (suggesting a uterus with greater fibroid-forming tendency) and in younger women with more remaining reproductive years. This is not a failure of the surgery — it is the underlying fibroid-forming tendency of the uterus expressing itself again.
Uterine Fibroid Embolisation (UFE): Approximately 20–30% of women require additional treatment within 5 years of UFE. Recurrence rates are comparable to or slightly lower than myomectomy in most studies, though the definition of “recurrence” differs between studies (new growth vs. symptom return).
Endometrial ablation: Addresses heavy bleeding but does not treat fibroids. Fibroids continue to grow post-ablation. Symptom recurrence is common if fibroids were significant at the time of ablation.
Hysterectomy: The only definitive cure. By definition, fibroids cannot recur after complete removal of the uterus.
Why Fibroids Recur
Treatment removes existing fibroids — it does not change the underlying hormonal and genetic environment that produced them. New fibroids develop from individual smooth muscle cells in the uterine wall. If the conditions that enabled the first generation of fibroids — estrogen exposure, inflammatory environment, genetic susceptibility — persist, new fibroids will form.
This is why age matters so much for recurrence risk. A woman who has myomectomy at 32 has 15–20 years of estrogen exposure ahead of her before menopause. A woman who has myomectomy at 44 may have only 5–8 years before the hormonal environment changes fundamentally. The recurrence risk is real in both cases, but its practical significance is very different.
What Reduces Recurrence Risk
The same lifestyle factors that reduce initial fibroid risk also reduce recurrence risk after treatment. The logic is the same: reduce the hormonal and inflammatory conditions that support fibroid development.
Anti-inflammatory diet: Consistently reducing the dietary inputs that raise estrogen and promote inflammation — red meat, refined carbohydrates, alcohol — changes the tissue environment over months. See our complete fibroid diet guide.
Maintain a healthy body weight: Adipose tissue produces estrogen via aromatase. Women who gain significant weight post-treatment face higher circulating estrogen and higher recurrence risk. Regular exercise post-treatment is one of the most evidence-based ways to maintain body composition and reduce this risk.
Hormonal management post-treatment: Some gynaecologists recommend the levonorgestrel IUD after myomectomy to reduce the estrogenic stimulation at the endometrial level. This is worth discussing explicitly as part of post-surgical planning.
Monitoring: Annual ultrasound after treatment allows early detection of new fibroids while they are still small and treatment options remain broader. “No symptoms” does not mean “no fibroids” — many small fibroids are asymptomatic.
The Realistic Frame
Recurrence is common enough to plan for, not to be surprised by. The right frame is: treatment addresses the current problem, and a consistent post-treatment lifestyle strategy reduces the probability and rate of new fibroid formation. The goal is not a permanent cure — it is the longest possible symptom-free interval and the smallest possible future fibroid burden.
Related reading: Fibroid Treatment Options: From Watchful Waiting To Surgery — What Each One Means · Fibroids And Sleep: Why You Wake Up At 3am And How To Break The Cycle · How Chronic Stress Makes Fibroids Worse — And 5 Ways To Break The Cycle
